查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
到 2030 年自动并行胜胜肽合成仪的市场预测：按类型、应用和区域分類的全球分析
市场调查报告书
商品编码
1383341

到 2030 年自动并行胜胜肽合成仪的市场预测：按类型、应用和区域分類的全球分析

Automatic Parallel Peptide Synthesiser Market Forecasts to 2030 - Global Analysis By Type (Fully-Automatic and Semi-Automatic), Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球自动化胜肽合成仪市场规模为 6.01 亿美元，预计在预测期内年复合成长率为 9.4%，到 2030 年将达到 11.27 亿美元。

自动并行胜胜肽合成仪是生物学和化学领域用于自动合成胜胜肽的专用工具。蛋白质主要由胜肽组成，胜肽是胺基酸的短链。胜肽合成仪是科学家和研究人员用来产生精确胺基酸序列的工具，用于药物开发、蛋白质研究、生化研究等。某些合成器还可能具有整合的胜胜肽精製和分析功能，例如质谱和高效液相层析(HPLC)。

对基于胜肽的疗法的需求不断增长

由胜肽和蛋白质製成的药物称为“胜肽疗法”，包括胜肽药物和生技药品。胜肽药物由于具有比传统小分子药物低毒性和更高特异性的特殊优势，在生物技术和製药领域越来越受欢迎。高标靶特异性是胜肽疗法的一个众所周知的特征，因此它们可以被设计为作用于特定的蛋白质、细胞或受体。此外，随着对更个体化和加护治疗的需求的增加，越来越需要由自动并行胜胜肽合成仪生产的客製化设计的胜肽。

缺乏技术纯熟劳工

对高素质劳动力的需求可能会让新兴企业、小型研究机构和资金有限的公司难以起步。此外，还需要花费大量的时间和金钱来培训人力资源来操作自动合成仪并进行胜肽合成。当关键人员离开或无法使用时，严重依赖技术纯熟劳工的企业可能会遇到困难，而依赖少数人可能会带来危险或扰乱业务，市场成长将受到阻碍。

个人化医疗日益受到关注

个人化医疗的目标是根据患者独特的遗传和分子特征进行治疗。有可能创造出专门特异性与患者疾病相关的基因突变和生物标记并与之相互作用的胜肽。透过自动平行胜肽合成仪可以快速有效地合成患者特异性胜胜肽。透过客製化胜胜肽，我们可以针对每个人疾病的遗传和生化特征做出反应。基因组学和 DNA 测序新兴市场的开拓使得检测与疾病相关的特定遗传变异和突变成为可能，从而使自动胜肽能够产生精确靶向这些遗传标记的胜肽。市场。

技术过时

较旧的合成器可能不具有与较新版本相同的特性、功能或效率。由于消费者被最新的创新所吸引并且不再投资过时的机器，老式合成器的製造商可能面临较少的竞争。新一代合成器配件和软体可能无法与早期型号配合使用，这限制了您利用最新功能并将您的仪器与其他实验室系统和设备连接的能力。

COVID-19 的影响

这场流行病加速了对抗病毒胜肽的寻找，这对于创造治疗方法和疫苗接种至关重要。因此，需要胜肽合成仪来生产抗病毒胜胜肽。 COVID-19 疫苗的快速发展推动了对这种胜肽合成仪的需求，其中一些疫苗的配方中含有胜肽。对远端工作和社会隔离的需求促使组织探索设备的自动化和远端监控，特别是胜肽合成器。此外，政府加大了对 COVID-19 相关的疫苗生产和研究的支持，使得购买胜肽合成器成为可能。

预计全自动细分市场在预测期内将是最大的

全自动部分预计将有良好的成长，因为这些胜肽合成步骤可以在全自动合成仪上同时处理，从而实现高通量胜胜肽生产。这些合成仪确保了胜肽的合成，因为可以精确控制温度、时间和试剂浓度等反应参数。另外，高效液相层析（HPLC）和质谱是某些全自动合成仪提供的两种整合精製和分析能力，可以快速生产纯胜胜肽并扩大市场。我会支持你。

医疗级预计在预测期内年复合成长率最高

医疗级自动平行胜肽合成仪是为满足医疗和医疗产业的特定要求而设计的专用工具，因此，医疗领域预计在预测期内将呈现最高的年复合成长率。这些合成器的主要应用是自动合成医学重要的胜肽，例如用于药物开发、诊断测试和治疗应用的胜肽。在医学研究中，基于胜肽的疫苗接种用于诱导免疫反应。这些疫苗的胜肽成分必须使用自动合成仪自动合成。

比最大的地区

由于生物技术、製药和生命科学领域的研发活动大幅增加，预计亚太地区在预测期内将占据最大的市场占有率。这些研究很大程度上依赖胜肽合成，从而推动了对自动化平行胜胜肽合成器的需求。由于基因组学、蛋白质组学和定制医学等生物技术的进步，对胜肽合成器的需求越来越大，这些进步被用于生物标记识别、诊断分析的创建和个体化胜肽治疗。

复合年复合成长率最高的地区：

由于药品研发集中在欧洲，预计欧洲在预测期内的年复合成长率最高。该地区积极参与多项药物研究和药物研发发现计划，包括生技药品和胜肽药物的合成。许多提供客製化胜胜肽合成服务的公司都位于欧洲。此外，其他地区的製药公司与欧洲研究机构之间的合作日益增多，也增加了对先进胜胜肽合成设备的需求。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与企业的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球自动并行胜胜肽合成器市场：按类型

  • 介绍
  • 全自动
  • 半自动

第6章全球自动平行胜胜肽合成器市场：按应用

  • 介绍
  • 医疗保健
  • 实验室
  • 其他用途

第7章全球自动并行胜胜肽合成器市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 中东和非洲其他地区

第8章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第9章公司简介

  • Activotec
  • MultiSynTech GmbH
  • CEM GmbH
  • Biotage
  • AAPPTEC
  • PolyPeptide Group
  • CreoSalus
  • AnproTech Inc.
  • Telegenixx
  • Almac Group
  • Next Pharma Inc.
Product Code: SMRC24191

According to Stratistics MRC, the Global Automatic Parallel Peptide Synthesiser Market is accounted for $601 million in 2023 and is expected to reach $1127 million by 2030 growing at a CAGR of 9.4% during the forecast period. A specialized tool used in biology and chemistry for the automated synthesis of peptides is an automatic parallel peptide synthesizer. Proteins are mostly made up of peptides, which are short chains of amino acids. Peptide synthesizers are tools used by scientists and researchers to manufacture precise amino acid sequences for use in medication development, protein studies, and biochemical research, among other uses. Certain synthesizers may be equipped with integrated peptide purification and analysis functions, such as mass spectrometry or high-performance liquid chromatography (HPLC).

Market Dynamics:

Driver:

Rising demand for peptide-based therapeutics

Pharmaceuticals made from peptides or proteins are referred to as "peptide-based therapeutics," which also includes peptide medications and biologics. They are becoming more and more well-known in the biotechnology and pharmaceutical sectors because of their special benefits, which include reduced toxicity and higher specificity than conventional small molecule medications. High target specificity is a well-known characteristic of peptide-based therapies thus they may be engineered to engage with particular proteins, cells, or receptors. Moreover, custom-designed peptides produced by automated parallel peptide synthesizers are becoming more and more necessary as the need for more individualized and focused therapies rises.

Restraint:

Lack of availability of a skilled workforce

The requirement for a highly qualified labor may make it difficult for startups, smaller research institutions, and enterprises with tight funds to get started. These organizations can find it difficult to draw in and keep people with the right kind of experience and it can take a lot of time and money to train people to operate automated synthesizers and perform peptide synthesis. Businesses that depend significantly on skilled workers may experience difficulties if important individuals depart or are unavailable where reliance on a small number of people might result in dangers and interruptions to operations thereby hindering the growth of the market.

Opportunity:

Growing focus on personalized medicine

Treating patients according to their unique genetic and molecular profiles is the goal of personalized medicine. It is possible to create peptides that specifically target and interact with genetic variants or biomarkers linked to a patient's illness. Rapid and effective synthesis of peptides tailored to a patient is made possible by automatic parallel peptide synthesizers. The distinct genetic and biochemical features of each person's illness can be catered for by customizing these peptides. It is now feasible to detect certain genetic variants and mutations linked to illnesses because to developments in genomics and DNA sequencing thus peptides that precisely target these genetic markers can be created using automatic peptide synthesizers which propels the market growth.

Threat:

Technological obsolescence

Older synthesizers might not have the same features, functionalities, or efficiency as more recent versions. Manufacturers of older synthesizers may face less competition as a result of consumers who are drawn to the newest innovations and may be discouraged from investing in antiquated machinery. It's possible that accessories and software from more recent generations of synthesizers won't work with earlier models, which would restrict capacity to utilize the newest features and link your equipment with other lab systems and instruments.

COVID-19 Impact

Research into antiviral peptides, which are essential for creating cures and vaccinations, was expedited by the epidemic. The need for peptide synthesizers to produce antiviral peptides arose as a result thus the need for peptide synthesis equipment was fueled by the COVID-19 vaccines' quick development, several of which contain peptides in their formulations. Organizations are investigating automation and remote monitoring of equipment, particularly peptide synthesizers, due to the necessity for distant work and social isolation. Moreover, increasing government support for vaccine production and research connected to COVID-19 made it possible to purchase peptide synthesizers.

The fully-automatic segment is expected to be the largest during the forecast period

The fully-automatic segment is estimated to have a lucrative growth, as these peptide synthesis processes may be handled concurrently by fully-automatic synthesizers, allowing for high-throughput peptide manufacturing. Peptide synthesis is guaranteed by these synthesizers because they provide exact control over reaction parameters like temperature, duration, and reagent concentrations. Furthermore high-performance liquid chromatography (HPLC) and mass spectrometry are two integrated purification and analysis features that certain fully-automatic synthesizers offer, making it possible to produce pure peptides quickly thus encouraging in the market expansion.

The medical segment is expected to have the highest CAGR during the forecast period

The medical segment is anticipated to witness the highest CAGR growth during the forecast period, because the medical-grade automatic parallel peptide synthesizers are specialist tools made to meet the specific requirements of the healthcare and medical industries. The automated synthesis of peptides of medical significance, such as those employed in medication development, diagnostic tests, and therapeutic applications, is the main usage for these synthesizers. Medical research use vaccinations based on peptides to elicit immune responses. The peptide components of these vaccines must be synthesized automatically using automatic synthesizers.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the biotechnology, pharmaceutical, and life sciences sectors which are seeing a significant increase in research and development activity in the Asia-Pacific area. These studies heavily rely on peptide synthesis, which fuels the need for automated parallel peptide synthesizers. Peptide synthesizers are becoming more and more in demand because to advancements in biotechnology such as genomics, proteomics, and customized medicine, these advancements are being used to biomarker identification, the creation of diagnostic assays, and individualized peptide therapeutics.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to Research & development for pharmaceuticals which are concentrated in Europe. The area is actively involved in several drug research and discovery initiatives, many of which entail the synthesis of biologics and peptide-based medications. Numerous businesses offering bespoke peptide synthesis services are based in Europe. Additionally, due to the increasing number of collaborations between pharmaceutical corporations from other areas and European research institutes is driving up the demand for sophisticated equipment for peptide synthesis.

Key players in the market

Some of the key players profiled in the Automatic Parallel Peptide Synthesiser Market include: Activotec, MultiSynTech GmbH, CEM GmbH, Biotage, AAPPTEC, PolyPeptide Group, CreoSalus, AnproTech Inc., Telegenixx, Almac Group and Next Pharma Inc.

Key Developments:

In June 2023, Biotage completes the acquisition of Astrea Bioseparations and resolves on a share issue to the Sellers as part of the acquisition. The acquisition also includes the shares held by certain minority investors in the Astrea group.

In March 2021, Activotec collaborated with Coronex to develop a game-changing platform for lateral flow (LF) tests that could be vital in the fight against COVID-19. This proprietary platform technology has been used to develop highly optimised LF tests for SARS-Cov-2 antibodies.

In February 2021, MultiSynTech GmbH and Biotage AB join forces and enter the peptide synthesis business. The agreements with MultiSynTech will grant Biotage distribution rights for all current MultiSynTech peptide synthesis systems.

Types Covered:

  • Fully-Automatic
  • Semi-Automatic

Applications Covered:

  • Medical
  • Laboratory
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Automatic Parallel Peptide Synthesiser Market, By Type

  • 5.1 Introduction
  • 5.2 Fully-Automatic
  • 5.3 Semi-Automatic

6 Global Automatic Parallel Peptide Synthesiser Market, By Application

  • 6.1 Introduction
  • 6.2 Medical
  • 6.3 Laboratory
  • 6.4 Other Applications

7 Global Automatic Parallel Peptide Synthesiser Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Activotec
  • 9.2 MultiSynTech GmbH
  • 9.3 CEM GmbH
  • 9.4 Biotage
  • 9.5 AAPPTEC
  • 9.6 PolyPeptide Group
  • 9.7 CreoSalus
  • 9.8 AnproTech Inc.
  • 9.9 Telegenixx
  • 9.10 Almac Group
  • 9.11 Next Pharma Inc.

List of Tables

  • Table 1 Global Automatic Parallel Peptide Synthesiser Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Automatic Parallel Peptide Synthesiser Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Automatic Parallel Peptide Synthesiser Market Outlook, By Fully-Automatic (2021-2030) ($MN)
  • Table 4 Global Automatic Parallel Peptide Synthesiser Market Outlook, By Semi-Automatic (2021-2030) ($MN)
  • Table 5 Global Automatic Parallel Peptide Synthesiser Market Outlook, By Application (2021-2030) ($MN)
  • Table 6 Global Automatic Parallel Peptide Synthesiser Market Outlook, By Medical (2021-2030) ($MN)
  • Table 7 Global Automatic Parallel Peptide Synthesiser Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 8 Global Automatic Parallel Peptide Synthesiser Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 9 North America Automatic Parallel Peptide Synthesiser Market Outlook, By Country (2021-2030) ($MN)
  • Table 10 North America Automatic Parallel Peptide Synthesiser Market Outlook, By Type (2021-2030) ($MN)
  • Table 11 North America Automatic Parallel Peptide Synthesiser Market Outlook, By Fully-Automatic (2021-2030) ($MN)
  • Table 12 North America Automatic Parallel Peptide Synthesiser Market Outlook, By Semi-Automatic (2021-2030) ($MN)
  • Table 13 North America Automatic Parallel Peptide Synthesiser Market Outlook, By Application (2021-2030) ($MN)
  • Table 14 North America Automatic Parallel Peptide Synthesiser Market Outlook, By Medical (2021-2030) ($MN)
  • Table 15 North America Automatic Parallel Peptide Synthesiser Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 16 North America Automatic Parallel Peptide Synthesiser Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 17 Europe Automatic Parallel Peptide Synthesiser Market Outlook, By Country (2021-2030) ($MN)
  • Table 18 Europe Automatic Parallel Peptide Synthesiser Market Outlook, By Type (2021-2030) ($MN)
  • Table 19 Europe Automatic Parallel Peptide Synthesiser Market Outlook, By Fully-Automatic (2021-2030) ($MN)
  • Table 20 Europe Automatic Parallel Peptide Synthesiser Market Outlook, By Semi-Automatic (2021-2030) ($MN)
  • Table 21 Europe Automatic Parallel Peptide Synthesiser Market Outlook, By Application (2021-2030) ($MN)
  • Table 22 Europe Automatic Parallel Peptide Synthesiser Market Outlook, By Medical (2021-2030) ($MN)
  • Table 23 Europe Automatic Parallel Peptide Synthesiser Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 24 Europe Automatic Parallel Peptide Synthesiser Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 25 Asia Pacific Automatic Parallel Peptide Synthesiser Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 Asia Pacific Automatic Parallel Peptide Synthesiser Market Outlook, By Type (2021-2030) ($MN)
  • Table 27 Asia Pacific Automatic Parallel Peptide Synthesiser Market Outlook, By Fully-Automatic (2021-2030) ($MN)
  • Table 28 Asia Pacific Automatic Parallel Peptide Synthesiser Market Outlook, By Semi-Automatic (2021-2030) ($MN)
  • Table 29 Asia Pacific Automatic Parallel Peptide Synthesiser Market Outlook, By Application (2021-2030) ($MN)
  • Table 30 Asia Pacific Automatic Parallel Peptide Synthesiser Market Outlook, By Medical (2021-2030) ($MN)
  • Table 31 Asia Pacific Automatic Parallel Peptide Synthesiser Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 32 Asia Pacific Automatic Parallel Peptide Synthesiser Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 33 South America Automatic Parallel Peptide Synthesiser Market Outlook, By Country (2021-2030) ($MN)
  • Table 34 South America Automatic Parallel Peptide Synthesiser Market Outlook, By Type (2021-2030) ($MN)
  • Table 35 South America Automatic Parallel Peptide Synthesiser Market Outlook, By Fully-Automatic (2021-2030) ($MN)
  • Table 36 South America Automatic Parallel Peptide Synthesiser Market Outlook, By Semi-Automatic (2021-2030) ($MN)
  • Table 37 South America Automatic Parallel Peptide Synthesiser Market Outlook, By Application (2021-2030) ($MN)
  • Table 38 South America Automatic Parallel Peptide Synthesiser Market Outlook, By Medical (2021-2030) ($MN)
  • Table 39 South America Automatic Parallel Peptide Synthesiser Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 40 South America Automatic Parallel Peptide Synthesiser Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 41 Middle East & Africa Automatic Parallel Peptide Synthesiser Market Outlook, By Country (2021-2030) ($MN)
  • Table 42 Middle East & Africa Automatic Parallel Peptide Synthesiser Market Outlook, By Type (2021-2030) ($MN)
  • Table 43 Middle East & Africa Automatic Parallel Peptide Synthesiser Market Outlook, By Fully-Automatic (2021-2030) ($MN)
  • Table 44 Middle East & Africa Automatic Parallel Peptide Synthesiser Market Outlook, By Semi-Automatic (2021-2030) ($MN)
  • Table 45 Middle East & Africa Automatic Parallel Peptide Synthesiser Market Outlook, By Application (2021-2030) ($MN)
  • Table 46 Middle East & Africa Automatic Parallel Peptide Synthesiser Market Outlook, By Medical (2021-2030) ($MN)
  • Table 47 Middle East & Africa Automatic Parallel Peptide Synthesiser Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 48 Middle East & Africa Automatic Parallel Peptide Synthesiser Market Outlook, By Other Applications (2021-2030) ($MN)